Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Comfort Gloves Berhad (2127.KL)
MYR0.14
+0.00 (+0.00%)
MY KLS Healthcare Medical - Instruments & Supplies
Address
Lot 821 34750
Taiping, MY
Taiping, MY
CEO
Joo Yong Lau
Website
comfort-rubber.com.my
IPO
2000-01-03
ISIN MYL2127OO008
Description
Comfort Gloves Berhad, established in Taiping, Malaysia, in 1937, operates as an investment holding company. The firm is primarily involved in the manufacturing and worldwide distribution of latex gloves, serving customers in Malaysia, the United States, Asia, Europe, and Canada. Its product range includes natural rubber, nitrile, and specialized gloves, alongside offering management services. The company's activities are organized across its Manufacturing, Investment Holding, Trading, and Other segments. Prior to its name change in August 2015, the entity was known as Integrated Rubber Corporation Berhad.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
MYR0.14
+0.00 (+0.00%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
563.8K
Beta
-0.27
Float Shares
336.01M
Free Float %
58.0%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | -6.90% | +0.00% | -15.63% | -25.00% | -59.09% | -65.38% | -94.03% | -81.12% | -99.03% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
0.14
DCF (Unlevered)
0.48
+254.7%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
1.74
Distress
Piotroski F-Score
5 / 9
Average
MOAT Score
0 / 10
No MOAT
Composite Rating
B-
Overall Score
2 / 5
Medium
DCF Score
3 / 5
Medium
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
3 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
5 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Instruments & Supplies: +7.9%-3.8% Q1'26: -36.4% (vs Q1'25)
-
EPS growth Medical - Instruments & Supplies: +16.3%-159.3% Q1'26: +39.9% (vs Q1'25)
-
FCF margin FCF growth · Medical - Instruments & Supplies: +27.1%-25.8% Q1'26: -13.1% (vs Q1'25)
-
EBIT margin Medical - Instruments & Supplies: +13.5%-42.7% Q1'26: -10.9% (vs Q1'25)
-
ROIC Medical - Instruments & Supplies: +6.0%-25.7% Q1'26: -5.2% (vs Q1'25)
-
Share dilution Medical - Instruments & Supplies: +0.1%-0.1% ★ Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Instruments & Supplies: -0.24×-0.25× Q1'26: 89.23× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
Dec 2029 1 Rev. Ana. 1 EPS Ana. |
Dec 2030 1 Rev. Ana. 1 EPS Ana. |
Dec 2031 1 Rev. Ana. 1 EPS Ana. |
Dec 2032 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
262.99M
est: 421.20M (-37.6%)
|
421.18M
est: 441.40M (-4.6%)
|
474.03M
est: 511.00M (-7.2%)
|
510.74M
est: 1.02B (-49.9%)
|
946.45M
est: 1.76B (-46.3%)
|
1.39B
est: 1.76B (-21.0%)
|
606.68M
est: 860.00M (-29.5%)
|
325.88M
est: 979.00M (-66.7%)
|
421.20M
421.20M – 421.20M
-57.0% YoY
|
441.40M
441.40M – 441.40M
+4.8% YoY
|
511.00M
511.00M – 511.00M
+15.8% YoY
|
1.02B
1.02B – 1.02B
+99.4% YoY
|
1.76B
1.76B – 1.76B
+72.8% YoY
|
860.00M
860.00M – 860.00M
-51.2% YoY
|
979.00M
979.00M – 979.00M
+13.8% YoY
|
| EBITDA |
34.17M
est: 63.08M (-45.8%)
|
53.77M
est: 66.11M (-18.7%)
|
52.83M
est: 76.53M (-31.0%)
|
67.58M
est: 152.61M (-55.7%)
|
393.75M
est: 263.74M (+49.3%)
|
581.31M
est: 263.74M (+120.4%)
|
-13.13M
est: 128.80M (-110.2%)
|
-626.0K
est: 146.62M (-100.4%)
|
2.22M
2.22M – 2.22M
-98.5% YoY
|
2.33M
2.33M – 2.33M
+4.8% YoY
|
2.69M
2.69M – 2.69M
+15.8% YoY
|
5.37M
5.37M – 5.37M
+99.4% YoY
|
9.28M
9.28M – 9.28M
+72.8% YoY
|
4.53M
4.53M – 4.53M
-51.2% YoY
|
5.16M
5.16M – 5.16M
+13.8% YoY
|
| EBIT |
25.71M
est: 30.34M (-15.3%)
|
41.42M
est: 31.80M (+30.3%)
|
36.91M
est: 36.81M (+0.3%)
|
45.55M
est: 73.40M (-37.9%)
|
366.09M
est: 126.85M (+188.6%)
|
540.29M
est: 126.85M (+325.9%)
|
-58.29M
est: 61.95M (-194.1%)
|
-45.83M
est: 70.52M (-165.0%)
|
-38.21M
-38.21M – -38.21M
-154.2% YoY
|
-40.04M
-40.04M – -40.04M
-4.8% YoY
|
-46.35M
-46.35M – -46.35M
-15.8% YoY
|
-92.43M
-92.43M – -92.43M
-99.4% YoY
|
-159.74M
-159.74M – -159.74M
-72.8% YoY
|
-78.01M
-78.01M – -78.01M
+51.2% YoY
|
-88.81M
-88.81M – -88.81M
-13.8% YoY
|
| Net Income |
25.87M
est: 34.20M (-24.4%)
|
35.90M
est: 28.98M (+23.9%)
|
27.90M
est: 34.78M (-19.8%)
|
33.18M
est: 272.41M (-87.8%)
|
280.22M
est: 539.02M (-48.0%)
|
421.52M
est: 539.02M (-21.8%)
|
-42.30M
est: 63.76M (-166.4%)
|
-36.81M
est: 63.76M (-157.7%)
|
34.16M
34.16M – 34.16M
-46.4% YoY
|
28.95M
28.95M – 28.95M
-15.3% YoY
|
34.74M
34.74M – 34.74M
+20.0% YoY
|
272.13M
272.13M – 272.13M
+683.3% YoY
|
538.47M
538.47M – 538.47M
+97.9% YoY
|
63.69M
63.69M – 63.69M
-88.2% YoY
|
63.69M
63.69M – 63.69M
+0.0% YoY
|
| SGA |
27.67M
est: 35.61M (-22.3%)
|
20.53M
est: 37.32M (-45.0%)
|
26.04M
est: 43.20M (-39.7%)
|
20.31M
est: 86.15M (-76.4%)
|
41.66M
est: 148.88M (-72.0%)
|
150.10M
est: 148.88M (+0.8%)
|
54.21M
est: 72.71M (-25.4%)
|
30.84M
est: 82.77M (-62.7%)
|
55.98M
55.98M – 55.98M
-32.4% YoY
|
58.66M
58.66M – 58.66M
+4.8% YoY
|
67.91M
67.91M – 67.91M
+15.8% YoY
|
135.42M
135.42M – 135.42M
+99.4% YoY
|
234.03M
234.03M – 234.03M
+72.8% YoY
|
114.29M
114.29M – 114.29M
-51.2% YoY
|
130.11M
130.11M – 130.11M
+13.8% YoY
|
| EPS |
0.05
est: 0.06 (-21.5%)
|
0.06
est: 0.05 (+28.4%)
|
0.05
est: 0.06 (-17.3%)
|
0.06
est: 0.47 (-87.8%)
|
0.48
est: 0.93 (-48.4%)
|
0.79
est: 0.93 (-15.1%)
|
-0.07
est: 0.11 (-166.3%)
|
-0.06
est: 0.11 (-157.8%)
|
0.06
0.06 – 0.06
-46.4% YoY
|
0.05
0.05 – 0.05
-15.3% YoY
|
0.06
0.06 – 0.06
+20.0% YoY
|
0.47
0.47 – 0.47
+683.3% YoY
|
0.93
0.93 – 0.93
+97.9% YoY
|
0.11
0.11 – 0.11
-88.2% YoY
|
0.11
0.11 – 0.11
+0.0% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-26 | B- | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-25 | B- | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-22 | B- | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-21 | B- | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-20 | B- | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-19 | B- | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-18 | B- | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-15 | B- | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-14 | B- | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-13 | B- | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-12 | B- | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-11 | B- | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-08 | B- | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-07 | B- | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-06 | B- | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-05 | B- | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-04 | B- | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-04-30 | B- | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-04-29 | B- | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-04-28 | B- | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-04-27 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-24 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-23 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-22 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-21 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-20 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-17 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-16 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-33.33M
OE per share TTM
-0.06
Owner's Yield
-42.64%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
61.7%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
This company is not held by any ETF in our universe.
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
-83.6K
Shares Outstanding
579.00M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Choi Ling Leong | Chief Financial Officer | — | female |
| Guang Lau | Executive Chairman | — | male |
| Joo Pern Lau | Executive Director | — | male |
| Joo Yong Lau | Group Chief Executive Officer & Executive Director | — | male |
| Youn Kim Wong MAICSA | Company Secretary | — | female |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 2127.KL
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
